Literature DB >> 16490179

Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodium falciparum in Iran.

J Ursing1, S Zakeri, J P Gil, A Björkman.   

Abstract

Plasmodium falciparum resistance to chloroquine (CQ) has been documented in Iran since the early 1980s and has since gradually increased. Iran is therefore reviewing its national drug policy for malaria control. We describe the prevalence of single nucleotide polymorphisms (SNP) associated with quinoline drug resistance in south eastern Iran. Pre-treatment blood from patients with uncomplicated but symptomatic P. falciparum infection was analysed. Polymorphisms at codons 76, 152, 163 and 220 of the pfcrt gene (chloroquine resistance transporter) and at codons 86, 184, 1034, 1042 and 1246 of the pfmdr1 gene (multidrug resistance) were determined by PCR-RFLP and sequencing. In addition, SNPs on a recently described multidrug resistance protein (pfmrp) and a microsatellite (MS-4760) in the pfnhe-1 (sodium hydrogen exchanger) gene associated with quinoline and quinine resistance, respectively, were investigated for the first time in field samples not from Thailand. pfcrt 76T was found in 99% and pfmdr1 86Y in 72% of the samples. pfmrp 191H and 437S associated with decreased quinoline response were found to be absolutely linked at a frequency of 13.6%. The pfnhe-1 MS-4760 one repeat allele associated to quinine response in vitro was also detected. Sequencing of the pfcrt 72-76 haplotype revealed that SVMNT was the most common allele as previously observed in India. This suggests that pfcrt found in the Iranian P. falciparum population may have the same origin as in the P. falciparum populations in India but different from that normally found in south east Asia. In conclusion, the frequencies of quinoline resistance associated gene polymorphisms in this region suggest a population that has been significantly selected for by the long use of CQ.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490179     DOI: 10.1016/j.actatropica.2006.01.002

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  23 in total

1.  Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum.

Authors:  Stéphane Pelleau; Lionel Bertaux; Sébastien Briolant; Michael T Ferdig; Véronique Sinou; Bruno Pradines; Daniel Parzy; Ronan Jambou
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

2.  Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar.

Authors:  Bhavna Gupta; Shuhui Xu; Zenglei Wang; Ling Sun; Jun Miao; Liwang Cui; Zhaoqing Yang
Journal:  J Antimicrob Chemother       Date:  2014-05-22       Impact factor: 5.790

3.  Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.

Authors:  Rajeev K Mehlotra; Gabriel Mattera; Moses J Bockarie; Jason D Maguire; J Kevin Baird; Yagya D Sharma; Michael Alifrangis; Grant Dorsey; Philip J Rosenthal; David J Fryauff; James W Kazura; Mark Stoneking; Peter A Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

4.  Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.

Authors:  Maria Isabel Veiga; Nuno S Osório; Pedro Eduardo Ferreira; Oscar Franzén; Sabina Dahlstrom; J Koji Lum; Francois Nosten; José Pedro Gil
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

5.  Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine.

Authors:  Juliana Martha Sá; Olivia Twu; Karen Hayton; Sahily Reyes; Michael P Fay; Pascal Ringwald; Thomas E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

Review 6.  Current therapies and future possibilities for drug development against liver-stage malaria.

Authors:  Rene Raphemot; Dora Posfai; Emily R Derbyshire
Journal:  J Clin Invest       Date:  2016-06-01       Impact factor: 14.808

7.  Analysis of gene mutations involved in chloroquine resistance in Plasmodium falciparum parasites isolated from patients in the southwest of Saudi Arabia.

Authors:  Saad M Bin Dajem; Ahmed Al-Qahtani
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

8.  Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.

Authors:  Bianca E Gama; Guilhermina A L Pereira-Carvalho; Florbela J I Lutucuta Kosi; Natália K Almeida de Oliveira; Filomeno Fortes; Philip J Rosenthal; Cláudio T Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Malar J       Date:  2010-06-18       Impact factor: 2.979

9.  Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.

Authors:  Véronique Parquet; Maud Henry; Nathalie Wurtz; Jerome Dormoi; Sébastien Briolant; Marine Gil; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2010-05-25       Impact factor: 2.979

10.  Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membrane.

Authors:  Reginald A Kavishe; Jeroen M W van den Heuvel; Marga van de Vegte-Bolmer; Adrian J F Luty; Frans G M Russel; Jan B Koenderink
Journal:  Malar J       Date:  2009-08-28       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.